BLENREP

Indicated For

relapsed or refractory multiple myeloma

About This Medication

# GSK Patient Assistance Program for BLENREP Patient Guide: How to Get BLENREP at Low or No Cost BLENREP (belantamab mafodotin) is a prescription medication used to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies, including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent. The **GSK Patient Assistance Program (PAP)** provides **BLENREP at no cost** to eligible patients who meet income, insurance, and residency requirements.[1][2][4][5] ## About BLENREP BLENREP is an antibody-drug conjugate that targets B-cell maturation antigen (BCMA) on multiple myeloma cells, delivering a cytotoxic agent directly to cancer cells while sparing healthy ones. It's administered as an intravenous infusion every three weeks by a healthcare professional. Common side effects include vision changes (monitor with eye exams), anemia, fever, and low platelets—discuss risks with your doctor. This program helps access treatment when costs are a barrier, but it does not replace insurance or medical advice.[1][6] ## Who Qualifies? To qualify for the **GSK PAP for BLENREP**, you must: - Reside in the US, DC, or Puerto Rico (not eligible if enrolled in Puerto Rico's Mi Salud plan without denial).[2][4][5] - Have a valid prescription for BLENREP from your doctor.[1][2] - Meet **income thresholds** based on household size and insurance status (uninsured, Medicare Part D, or functionally uninsured).[1][4][5] - For Medicare Part D: Spent $600 out-of-pocket on prescriptions this calendar year.[1][2][4] This program is **not health insurance** and requires annual recertification.[2] ## Income Eligibility Breakdown Income limits vary by insurance status, household size, and medical expenses (which may lower effective thresholds). Uninsured patients follow limits around **400% of the Federal Poverty Level (FPL)**. Exact thresholds (annual gross income) include:[1][5] | Household Size | Individual/Uninsured | Couple | Family of 3 | Family of 4 | |----------------|----------------------|--------|-------------|-------------| | **Example Thresholds** | ≤$48,000 | ≤$60,000 | ≤$72,000 | ≤$84,000 | **Notes**: Provide total gross monthly or annual household income on the form. Limits adjust for Medicare/insured status; high medical costs can reduce countable income. Call (844) 447-5662 for your situation.[1] ## Insurance Requirements Eligible if: - **Uninsured** (no prescription coverage).[5] - **Medicare Part D**: Proof of $600 spend + Medicare Beneficiary Identifier (MBI).[1][2][4] - **Functionally uninsured** (insurance denies BLENREP coverage).[1] Ineligible if covered by Medicaid, VA, DoD, or similar government programs. Private insurance patients may need copay programs instead.[6] ## Step-by-Step Application Process 1. **Talk to your doctor**: Get a signed original prescription for BLENREP (faxed only from doctor's office with cover sheet).[1][2] 2. **Gather documents**: - Proof of income (pay stubs, tax returns). - Proof of residency (utility bill). - Proof of insurance status (insurance cards or denial letter; Medicare: EOB showing $600 spend + ID card).[1][2] - Completed enrollment form.[1] 3. **Enroll online or by phone**: Visit https://www.togetherwithgsk.com/blenrep/patient/enroll/ or call **(844) 447-5662**.[1] 4. **Submit**: Fax/mail complete application + documents. Keep copies—originals not returned.[1][2] 5. **Sign authorizations**: Allow GSK to verify income/insurance and contact providers.[1][2] **Tip**: Incomplete apps delay processing—double-check![1][2] ## Timeline and Delivery Processing time varies (not specified; typically 2-4 weeks based on similar programs). Track via phone.[1] Medication ships **free to your home or doctor's office**.[1] **Reauthorization required** annually or per prescription cycle—resubmit updated info.[1] ## Alternatives if Denied - **Appeal**: Call (844) 447-5662 with new docs.[1] - **Other assistance**: GSK copay cards (insured patients), NeedyMeds, RxAssist, or state programs.[6] - **No biosimilars** for BLENREP currently.[1] - **Clinical trials** or generics via CancerCare/ Leukemia & Lymphoma Society. ## Disclaimer This guide is for informational purposes only and based on available program details as of 2026. Eligibility/rules change—verify with GSK at (844) 447-5662 or website. Not medical/financial advice; consult your doctor and advisor. GSK PAP not guaranteed; false info may disqualify you.[1][2]

Program information last verified: March 25, 2026